Comparison of community and healthcare-associated MRSA in Iran

Iranian Journal of Clinical Infectious Diseases

Volumn 5, Issue 4, 2010, Pages 206-212

  Moghadami, Mohsen ^a   Japoni, Aziz ^b   Karimi, Abdollah ^c   Mardani, Masuod ^d  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antibacterial susceptibility patterns; Community acquired MRSA; Healthcare associated MRSA; Staphylococcal cassette chromosome mec

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; OXACILLIN; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ADULT; AGAR DILUTION; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CHROMOSOME; BACTERIUM ISOLATION; CLINICAL FEATURE; COMMUNICABLE DISEASE; CONTROLLED STUDY; FEMALE; HOSPITAL INFECTION; HUMAN; INFANT; IRAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PROSPECTIVE STUDY; STAPHYLOCOCCAL CASSETTE CHROMOSOME MEC; UNIVERSITY HOSPITAL;

EID: 84857066911     PISSN: 17355109     EISSN: 20081081     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Evons J, Cow AW, Parker MT. Methicillin resistance in staphylococci. Lancet. 1963;27:904-7.
2. Barrett FF, McGehee RF Jr, Finland M. Methicillinresistant Staphylococcus aureus at Boston City Hospital: bacteriologic and epidemiologic observations. N Engl J Med. 1968;279:441-48.
3. MRSA in Healthcare Settings. Updated: October 3, 2007. Available at: http://www.cdc.gov/ncidod/dhqp/ar_MRSA_spotlight_2006.html.
4. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004. Am J Infect Control. 2004;32:470-85.
5. Salgado CD, Farr BM, Calfee DP. Communityacquired methicillin resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis. 2003;36:131-9.
6. Okuma K, Iwakawa K, Turnidge JD, Grubb WB, Bell JM, O'Brien FG, et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol. 2002;40:4289-94.
7. Dufour P, Gillet Y, Bes M, Lina G, Vandenesch F, Floret D, et al. Community-acquired methicillin resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis. 2002;35:819-24.
8. Chambers HF. The changing epidemiology of Staphylococcus aureus. Emerg Infect Dis. 2001;7:178-82.
9. Hamoudi AC, Palmer RN, King TL. Nafcillin resistant Staphylococcus aureus: a possible community origin. Infect Control. 1983;4:153-57.
10. Charlebois ED, Bangsberg DR, Moss NJ, Moore MR, Moss AR, Chambers HF, et al. Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis. 2002;34:425-33.
11. Charlebois ED, Perdreau-Remington F, Kreiswirth B, Bangsberg DR, Ciccarone D, Diep BA, et al. Origins of community strains of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2004;39:47-54.
12. Ma XX, Ito T, Tiensasitorn C, Jamklang M, Chongtrakool P, Boyle-Vavra S, et al. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother. 2002; 46:1147-52.
13. Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet. 2002;359:1819-27.
14. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, et al. Comparison of community-and health care-associated methicillinresistant Staphylococcus aureus infection. JAMA. 2003; 290:2976-84.
15. Milheiriço C, Oliveira DC, de Lencastre H. Update to the multiplex PCR strategy for assignment of mec element types in Staphylococcus aureus. Antimicrob Agents Chemother. 2007;51:3374-77.
16. National Committee for Clinical Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A6,2003; NCCLS, Wayne, PA, USA.
17. Fatholahzadeh B, Emaneini M, Gilbert G, Udo E, Aligholi M, Modarressi MH, et al. Staphylococcal cassette chromosome mec (SCCmec) analysis and antimicrobial susceptibility patterns of methicillinresistant Staphylococcus aureus (MRSA) isolates in Tehran, Iran. Microb Drug Resist. 2008;14:217-20.
18. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, et al. Active bacterial core surveillance program of the emerging infections program network methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005;352:1436-44.
19. Cercenado E, Ruiz de Gopegui E. Communityacquired methicillin-resistant Staphylococcus aureus. Enferm Infect Microbiol Clin. 2008;13:19-24.
20. Seybold U, Kourbatova EV, Johnson JG, Halvosa SJ, Wang YF, King MD, et al. Emergence of community associated methicillin resistant Staphylococcus aureus DSA 300 genotype as a major cause of health care associated blood stream infection. Clin Infect Dis. 2006; 42:647-56.
21. King A, Brown DF. Quality assurance of antimicrobial susceptibility testing by disc diffusion. J Antimicrob Chemother. 2001;48 Suppl 1:71-76.
22. Huang YC, Ho CF, Chen CJ, Su LH, Lin TY. Comparative molecular analysis of communityassociated and healthcare-associated methicillinresistant Staphylococcus aureus isolates from children in northern Taiwan. Clin Microbiol Infect. 2008;14:1167-72.
23. Ibrahem S, Salmenlinna S, Lyytikäinen O, Vaara M, Vuopio-Varkila J. Molecular characterization of methicillin-resistant Staphylococcus epidermidis strains from bacteraemic patients. Clin Microbiol Infect. 2008;14:1020-27.
24. Martinez-Aguilar G, Hammerman WA, Mason EO Jr, Kaplan SL. Clindamycin treatment of invasive infections caused by community-acquired methicillinresistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J. 2003; 22:593-98.
25. Szumowski JD, Cohen DE, Kanaya F, Mayer KH. Treatment and outcomes of infections by methicillinresistant Staphylococcus aureus at an ambulatory clinic. Antimicrob Agents Chemother. 2007;51:423-28.
26. Kaplan SL, Hulten KG, Gonzalez BE, Hammerman WA, Lamberth L, Versalovic J, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis. 2005; 40:1785-91.
27. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: seventeenth informational supplement. M100- S17 (NLSI), 2007 Wayne, PA, USA.
28. Frank AL, Marcinak JF, Mangat PD, Tjhio JT, Kelkar S, Schreckenberger PC, et al. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J. 2002; 21:530-34.
29. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, et al. Emergency ID Net Study Group. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666-74.
30. Frazee BW, Lynn J, Charlebois ED, Lambert L, Lowery D, Perdreau-Remington F. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med. 2005;45:311-20.